Cardiometabolic risk factor levels in Norwegian children compared to international reference values: The ASK study

Mette Stavnsbo; Turid Skrede; Eivind Aadland; Katrine N. Aadland; Mai Chinapaw; Sigmund A. Anderssen; Lars B. Andersen; Geir K. Resaland

doi:10.1371/journal.pone.0220239

Abstract

Objective

To investigate cardiometabolic risk factor levels in a group of Norwegian 10-year-old children compared to international values and examine the association between cardiorespiratory fitness (CRF) and the reference-standardized clustered risk score.

Methods

913 children (49% girls) were included from the Active Smarter Kids (ASK) study. Body mass index (BMI), waist circumference (WC), systolic blood pressure (SBP), diastolic blood pressure (DBP), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC) to HDL-C ratio, triglyceride (TG), glucose, insulin, homeostatic model assessment (HOMA) score and CRF, were standardized according to international age-and sex-specific reference values.

Results

The Norwegian children had significantly more favorable WC, DBP, glucose, HDL-C and CRF levels compared to the international reference values, but similar or less favorable levels of other cardiometabolic risk factors. CRF was the variable that differed the most from the international values (mean (95% CI) 1.20 (1.16 to 1.24) SD). The clustered risk score (excluding CRF) was higher in the Norwegian children, but decreased to below international levels when including CRF (mean (95% CI) - 0.08 (- 0.12 to –0.05) SD). CRF had a significant inverse association with the clustered risk score (excluding CRF) (β - 0.37 SD, 95% CI –0.43 to –0.31).

Conclusions

Norwegian children have substantially higher CRF levels than international standards, and including CRF in clustered risk scores reduces overall risk in Norwegian children below that of international levels. CRF is associated with improved cardiometabolic health in children.

Citation: Stavnsbo M, Skrede T, Aadland E, Aadland KN, Chinapaw M, Anderssen SA, et al. (2019) Cardiometabolic risk factor levels in Norwegian children compared to international reference values: The ASK study. PLoS ONE 14(8): e0220239. https://doi.org/10.1371/journal.pone.0220239

Editor: Louise H. Naylor, University of Western Australia, AUSTRALIA

Received: January 25, 2019; Accepted: July 11, 2019; Published: August 19, 2019

Copyright: © 2019 Stavnsbo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the manuscript and its Supporting Information files.

Funding: This work received support from the Research Council of Norway (grant number 221047/F40), Western Norway University of Applied Science, the Norwegian School of Sports Science and the Gjensidige Foundation (grant number 1042294).

Competing interests: The authors have declared that no competing interests exist.

Introduction

The clustering of cardiometabolic risk factors (hypertension, dyslipidemia, adiposity, and glucose intolerance) has its origin in childhood [1] and can track into adulthood [2].

These risk factors constitute the metabolic syndrome (MetS), but the use of different measures and ensembles of risk factors and thresholds [3–5] hampers comparison between studies. Further, dichotomization of risk factors to define cardiometabolic risk have several limitations, especially when carried out in children [6]. The dichotomization of biological traits ignores the continuous nature of risk and decreases the available information and thus power in statistical analysis. Moreover, since cardiovascular diseases are usually not manifested in children, the thresholds for classifying children as “healthy” or “at risk” [1, 7–9] are adapted from definitions in adults and introduce an arbitrary insincerity.

A large international reference material for cardiometabolic risk factor values in children and adolescents was recently published to deal with these issues [10]. The reference values can be used to standardize single cardiometabolic risk factors, allowing to compare otherwise population specific continuous clustered risk scores directly to the reference material itself and to other studies adapting the same approach. Thus, the study by Stavnsbo et al. [10] facilitate international comparisons of prevalence and trends in pediatric cardiometabolic risk.

Cardiorespiratory fitness (CRF) is a strong predictor of cardiometabolic disease and all-cause mortality in adults [11, 12]. In children, the evidence is less clear but CRF has been inversely associated with clustered cardiometabolic risk factors in an accumulating number of studies [13–17]. The primary aim of this paper was to investigate cardiometabolic risk factor levels in a group of Norwegian 10-year-old school-children as compared to international reference values. A secondary aim was to examine the association between CRF and the reference-standardized clustered risk score.

Materials and methods

Design and population

The present study is a cross-sectional analysis of baseline data from the Active Smarter Kids (ASK) study, a seven month cluster-randomized controlled trial conducted in the school year of 2014–2015 in Western Norway [18]. In total, 1129 5^th graders (94% of those invited) from 57 schools participated in the ASK study. We included 913 children (49% girls vs. 51% boys) age 10.2 (± 0.3) that had valid data in all cardiometabolic risk factors of interest. The ASK study design, sampling procedures and methodology is described in details elsewhere [18], thus, only a brief description of the relevant procedures are provided herein.

Blood sampling

An intravenous blood sample was collected from the children’s antecubital vein after an overnight fast. Serum were obtained following a standardized protocol. An ISO-certificated laboratory analyzed the serum samples for traditional risk factors related to cardiometabolic diseases; insulin, glucose, triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), and total cholesterol (TC). A TC to HDL-C (TC:HDL-C) ratio was calculated to represent dyslipidemia. Insulin resistance were defined by the homeostatic model assessment (HOMA)-score = [insulin (pmol/L) * glucose (mmol/L)]/135 [19].

Resting blood pressure

Systolic (SBP) and diastolic (DBP) blood pressure were measured by the Omron HEM-907 automated BP monitor (Omron Healthcare, Inc, Vernon Hills, IL, US). The device is validated according to the AAMI validation protocol [20] and to the validation criteria of the international protocol for BP measuring devices [21]. The children were measured in a quiet room after resting for ten minutes in a sitting position. Four measurements were taken with one-minute pauses in-between and the mean of the last three measurements was used for analyses. If the difference between measurements was >5 mmHg, we obtained one extra measurement, in which case the mean of the last four was calculated and used for analyses.

Anthropometry and sexual maturity

BMI.

Body mass was measured to the nearest 0.1 kg using an electronic scale (Seca 899, SECA GmbH, Hamburg, Germany) with children wearing light clothing or underwear (preferred) depending on the acceptance of the child. A portable Seca 217 (SECA GmbH, Hamburg, Germany) was used to measure stature to the nearest 0.1 cm with the barefooted child facing forward. Body mass index (BMI) (kg*m⁻²) was calculated as weight (kg) divided by the height squared (m²).

Waist circumference.

Waist circumference (WC) was measured using an ergonomic measuring tape (Seca 201, SECA GmbH, Hamburg, Germany). Two measures were taken between the lowest rib and the iliac crest to the nearest 0.5 cm with the child’s abdomen relaxed at the end of a gentle expiration. If the difference between measurements was greater than one cm, we obtained a new measurement until two results were ≤ 1 cm apart. The mean of the two closest measurements was used for analyses.

Maturity.

Pubertal stage was self-assessed by the child using the Tanner scale in color pictures as proposed by Carel and Leger [22]. The children were given the standardized series of images with explanatory text in a private room. The children were asked to put a checkmark in the box below the picture that best represented their stage (1 to 5) of development for each component. We used breast and genital development for girls and boys, respectively, as a measure of pubertal stage.

Demographic characteristics

We obtained self-reported educational level from the children’s parents/legal guardians to assess socio-economic status (SES). Parental education was categorized into three levels using the highest educational level obtained by the mother or father: i) upper or lower secondary school, ii) university < four years, and iii) university ≥ four years.

Cardiorespiratory fitness

Cardiorespiratory fitness levels were measured using the validated Andersen test [23, 24], an intermittent field-running test [23]. All children were tested indoor on a wooden or rubber hall floor. In groups of 10–20 children, participants ran a 20 meter distance between one end-line to another for 15 seconds and stood still for another 15 seconds. Children touched the floor with one hand behind the line each time before they turned around. The test lasted for 10 minutes, and the total distance (meters) covered was registered as the test result. The Andersen test performance was converted into VO_2peak by the following equation; girls VO_2peak = 32.5793 + (0.0309 × distance (m))–(0.2351 × body mass (kg)), boys VO_2peak = 27.1689 + (0.0397 × distance (m))–(0.1698 × body mass (kg)) [25].

Ethics

Our procedures and methods conform to ethical guidelines defined by the World Medical Association's Declaration of Helsinki and subsequent revisions [26]. The study protocol was approved by the Regional Committee for Medical Research Ethics (Reference Number: 2012/2304). Written informed consent was obtained from children’s parents or legal guardians prior to commencement to the study.

Statistics

Before analyses, all values exceeding five standard deviations from the mean were excluded from the data material. Skewed variables were logarithmically transformed by the natural logarithm (ln); BMI, WC, TG, TC:HDL-ratio, insulin and HOMA. A linear mixed model and a generalized estimating equation model including school as a random effect were used to examine differences between sexes for the continuous and categorical variables, respectively. The characteristics are presented as means and standard deviations (SD), median and interquartile range (IQR), or numbers and percentage (%). To enable comparison of single and clustered cardiometabolic risk factor values between Norwegian children and the international reference values, we standardized the following risk factors according to the age- and sex-specific reference values suggested by Stavnsbo et al. [10]; BMI (ln), WC (ln), SBP, DBP, LDL-C, HDL-C, TC:HDL-ratio (ln), TG (ln), glucose, insulin (ln), HOMA score (ln), and CRF (VO_2peak). Each single risk variable was standardized by sex using the following equation; reference-standardized variable (z-score) = , where age-predicted reference values were used as the mean (), calculated from regression equations for the single cardiometabolic risk factors [10]. A mean clustered reference-standardized risk score was calculated by summing up the z-scores WC, SBP, TC:HDL-ratio, TG, and HOMA score and divide by five [27]. A second mean clustered risk score was calculated including CRF (VO_2peak inversed) by summing up the same reference-standardized risk factors as described above and CRF, and divide by six [27].

The association between the Andersen test and the reference-standardized clustered risk score (excl. CRF) was explored using a linear mixed model; CRF as the independent variable, the reference-standardized clustered risk score as the dependent variable, and school as a random effect (to account for the cluster effect). Age, sex, pubertal stage and SES were included as covariates, but only sex and pubertal stage changed the estimates and were therefore included in an adjusted model. In line with previous studies [14, 15], we investigating if sex moderated the association between CRF and clustered cardiometabolic risk factors, testing the statistical additive assumption in linear regression analysis. Thus, sex differences were investigated by including the interaction CRF*sex. To produce interpretable beta coefficients, both CRF and the clustered risk score were standardized before analysis.

All analyses were conducted using IBM SPSS version 23 (IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp., USA). A p-value ≤ 0.05 was considered statistically significant in all analyses.

Results

Table 1 presents descriptive statistics of the study population. The majority of the children were pre-pubertal at baseline (88% girls and 89% boys) and 63–64% of both girls and boys had at least one parent with a professional bachelor degree (<4 years of higher education). There were no sex differences in mean age, height, BMI, WC, SBP, DBP or LDL. Girls had a significantly higher TC:HDL-ratio, TG, insulin, and HOMA score than boys, but lower CRF levels. Overall, girls had a less favorable risk score profile, represented by a higher clustered risk score (standardized by population specific means and SDs) than boys (p<0.001) (results not shown).

Download:

Table 1. Descriptive statistics of the study population by sex.

https://doi.org/10.1371/journal.pone.0220239.t001

Table 2 and Fig 1 shows the standardized difference in cardiometabolic risk factors and clustered risk scores between Norwegian children and international reference values from children of the same age and sex. Cardiorespiratory fitness differed the most of all standardized variables from the international reference values, showing significantly more favorable levels in the Norwegian children (mean (95% CI) 1.20 (1.16 to 1.24) SD). The Norwegian children also had significantly more favorable WC, DBP, HDL-C, and glucose levels in comparison to the international reference population. Less favorable levels were found for SBP, LDL-C, TG, insulin and HOMA score compared to the international standards. BMI and TC:HDL-ratio was not significantly different from the reference values. The clustered risk score (excluding CRF) was significantly higher in the Norwegian children compared to international values (mean (95% CI) 0.15 (0.11 to 0.19) SD). On the contrary, when including CRF as an additional risk factor, the mean clustered risk score decreased to below international levels (mean (95% CI) - 0.08 (- 0.12 to –0.05) SD).

Download:

Fig 1. Reference-standardized cardiometabolic risk factors.

Mean (95% CI) of the reference-standardized single risk factors and mean clustered risk scores excluding and including cardiorespiratory fitness (CRF) (inversed) in Norwegian children. Reference-standardized variable = , where age-predicted reference value was used as the mean () (10). The cardiometabolic clustered risk scores consisted of the following reference-standardized risk factors; WC, SBP, TG, TC:HDL-ratio, and HOMA score, excluding and including CRF (inversed).

https://doi.org/10.1371/journal.pone.0220239.g001

Download:

Table 2. Reference-standardized cardiometabolic risk factors^{^a} by gender according to Stavnsbo et al. [10].

https://doi.org/10.1371/journal.pone.0220239.t002

Cardiorespiratory fitness was significantly inversely associated with the reference-standardized clustered risk score (excluding CRF) (β - 0.37 SD, 95% CI –0.43 to –0.31), adjusted by sex and pubertal stage. There were no significant moderating effect of sex for the association between CRF and cardiometabolic clustered risk. Fig 2 illustrates the inverse association between quartiles of CRF (quartile 1 represents the least fit children and quartile 4 the most fit children) and the cardiometabolic reference-standardized clustered risk score in girls and boys (p for trend < 0.001).

Download:

Fig 2. Association between quartiles of cardiorespiratory fitness and the reference-standardized clustered risk score.

Mean (95% CI) of the reference-standardized clustered cardiometabolic risk score (excluding CRF) across quartiles of CRF. A higher clustered risk score indicates a less favorable cardiometabolic profile. Children in quartile 1 of CRF are the least fit and children in quartile 4 the fittest. P for trend < 0.001.

https://doi.org/10.1371/journal.pone.0220239.g002

Discussion

This is the first study to produce standardized cardiometabolic risk values according to the international reference material for cardiometabolic risk factors in children published by Stavnsbo et al. [10]. This method makes it possible to compare otherwise sample-specific clustered risk scores directly to international age- and sex-specific cardiometabolic risk values. The Norwegian children in the present study had a higher clustered risk score of traditional risk factors than the international reference population, due to higher levels of SBP, HOMA score, and TG. However, CRF was considerably higher in the Norwegian children and including CRF in the clustered risk score decreased the score to below international values.

Children from Nordic countries have earlier exhibited higher SBP values compared to children from other European countries [28, 29], which the present study confirms. Elevated BP levels have been associated with organ damage in children [30] and track moderately into adulthood, increasing the risk of subclinical atherosclerosis [31]. Systolic BP was included in the clustered risk score, although DBP was lower in the Norwegian children compared to the international reference values. Systolic BP has been argued for as a recommended measure in children due to a greater accuracy and reproducibility than measures of DBP [32], and is often used as a single component to represent BP levels in pediatric clustered risk scores [10]. In addition, SBP has been shown to be a better predictor of cardiometabolic risk compared to DBP in adults [33]. Norwegian adults have also shown to have higher SBP than many other European countries and the US [34]. Dietary differences between countries could possibly cause these variations in BP [35]. However, methodological differences could also be a plausible explanation for these findings. For instance, approximately 50% of the total population included in the reference material was drawn from the National Health and Nutrition Examination Survey (NHANES) from the USA, for which BP was measured by the use of a mercury sphygmomanometer. The auscultation method using a mercury sphygmomanometer is the “gold standard” for BP measures [36]. In the present study we used an oscillometric BP device to measure BP. When validated against the mercury sphygmomanometer, oscillometric BP devices have been shown to significantly overestimate SBP in children (2.53 mmHg; 95% CI [0.57 to 4.50]) [37]. In comparison, the difference between SBP values in the Norwegian 10-year-olds and the international age-comparable children was 2.48 mmHg (95% CI [1.93–3.02]). The accuracy, however, of BP measures also depends on other factors such as the surrounding environment in which the measures are completed, the measurement procedures, and the test personnel [38].

The children in the present study had significantly higher HOMA scores than the international reference population. HOMA score has been shown to be a good surrogate measure for insulin resistance in youth, when validated against the euglycemic-hyperinsulinemic clamp method [39]. Also, HOMA score has been shown to be a better predictor for clustered cardiometabolic risk factors, than fasting glucose and insulin levels alone [40]. During the last decades, prevalence rates of insulin resistance and type 2 diabetes in children and adolescents have been on the rise globally [41]. Comparing HOMA levels in the ASK study to population-based samples of 9-10-year-old Norwegian children from 2005–2006 [42], shows that Norwegian children may following international trends. When glucose and insulin was standardized separately according to the international reference values, the ASK population had slightly lower glucose values, but considerably higher insulin levels than the reference population. A potential methodological challenge when comparing insulin levels between populations is the use of different kits for analysis, since the binding characteristics of the plates may result slightly different. Storage time of blood samples before analyzes also influence on insulin levels. As an example of this, the multicultural European Youth Heart Study (EYHS), included in the reference material, had their Portuguese blood samples stored for several years before analysis. The Danish samples were analyzed shortly after collection in a WHO-certified laboratory. A subgroup of the Danish samples were reanalyzed to investigate the influence of the long storage time, showing a strong correlation between insulin values between the first and second analysis (r = 0.97), but a substantial decrease (≈ 50%) in insulin levels. Thus, insulin levels from EYHS-Portugal were corrected for storage time to apply to all other obtained insulin values in the EYHS study. It is, nevertheless, plausible that differences in storage time of blood samples in the studies included in the reference material and in the ASK study, could contribute to the higher insulin values and HOMA score observed in the present study.

Pediatric dyslipidemia is associated with initiation and progression of atherosclerotic lesions [43] and has shown persistence over time [44], increasing the risk of early atherosclerosis and premature cardiovascular diseases. Triglycerides and TC:HDL-ratio were included in the clustered risk score in the present study to represent dyslipidemia, and both have been widely used in clustered risk scores in pediatric populations [10]. Compared to the international reference population, TG levels were significantly higher in the Norwegian children. In stratified analysis, girls exhibited higher TG levels than the Norwegian boys. One explanation of this finding could be that TG concentrations are positively associated with sexual maturation [45], and girls have been shown to enter puberty at younger ages than observed previously [46]. For instance, the Copenhagen Puberty Study found that thelarche among Danish girls in 2006 started nearly one year earlier than it had 15 years previously, independently of changes in BMI [47]. The Norwegian children did not differ from the international reference population in TC:HDL-ratio, despite significantly higher HDL-C levels. High levels of HDL-C are positively correlated with CRF, which was higher in the present study than the international reference values, and HDL-C has been shown to have an anti-atherosclerotic, and to some extent also cardioprotective, effect [48]. Lipid and lipoproteins levels are, nonetheless, influenced by several environmental and genetic factors, such as diet [49] and apolipoprotein variants [50], which we were not able to control for.

Time trends in cardiometabolic risk factor levels in children and the fact that the reference values are based on pooled data from both European and US data, may explain some of the observed differences between the Norwegian and international risk factor values in general. The reference material comprised studies conducted between 1999 and 2008, while baseline data from the ASK study was collected in 2014. For instance, obesity levels in children and adolescents have shown a significant linear increase among children and adolescents during the last decades in both Europe and the US [51, 52]. The prevalence of obesity in Europe has, nevertheless, not increased to the same extent as in the US. According to the WHO [51], the mean prevalence of obesity among adolescents (11-, 13- and 15-year-olds) from 27 European countries was 4% in 2014. In comparison, the prevalence of obesity among US children aged 12–15 years in 2014 was 20% [52]. Further, the WHO reported that the lowest level of obesity in Europe in 2014 was found among Norwegian adolescents and Norway was one of the only European countries where an overall decrease in obesity was observed in the years between 2002 and 2014 (although only significant in 13-year-old boys) [51]. This might explain why the children in the present study had significantly lower WCs than the international reference children. The Norwegian children’s BMI did, however, not differ from the reference population, but WC was prioritized in the clustered risk score since WC has been shown to be a stronger predictor of cardiometabolic risk than is BMI [53–55]. Waist circumference is strongly inversely associated with CRF [16] and CRF levels in the present study were significantly higher than in the reference population.

Among the examined variables, CRF (VO_2peak) clearly differed the most from the international values, 1.20 and 1.23 SDs in girls and boys, respectively. Thus, when we included CRF (inversed) in the clustered risk score, the risk score decreased considerably. Cardiorespiratory fitness is associated with cardiometabolic health in both children [13, 14, 16, 17] and adults [56, 57]. In adults, low CRF has shown to be a stronger predictor of CVDs and all-cause mortality than other established risk factors, such as hypertension, type 2 diabetes and high cholesterol levels [11, 12, 56–58]. Furthermore, both epidemiological studies and clinical evidence show that CRF in addition to other traditional cardiometabolic risk factors enhances the precision of predicting CVD morbidity and mortality [56]. Although different fitness tests were used to produce reference values for CRF, these fitness tests rely on solid validations to reflect absolute VO_2peak [10]. In addition, VO_2peak in the present study was estimated from validated algorithms, but could possibly overestimate true VO_2peak values [24]. However, high CRF levels is in line with previous studies showing that Norwegian children have relatively high VO_2peak [42, 59]. In support of this findings, international comparisons of children´s PA levels show that Norwegian children are more physically active and spend more time in higher intensities than children from most other countries [60].

It is rather contradictory that the Norwegian children have higher clustered cardiometabolic risk levels despite lower WC and higher CRF, compared to international values. One would expect lower (healthier) cardiometabolic risk factor levels in a fit population. However, similar findings were reported in a previous study from Western Norway [16]. The reason for the discrepancy in these risk factor profiles is difficult to manifest, but it could be due to cultural or environmental factors or to any of the reasons discussed earlier, such as diet, genetics or methodologically differences. The ASK population is both lean and fit, and despite having higher levels of some cardiometabolic risk factors compared to international values, these levels are still considered to be within a healthy range. Importantly, cardiometabolic risk factor levels seems in general to have improved in children from Western Norway during the last decade [16].

The present study found an inverse association between CRF and clustered cardiometabolic risk (r = - 0.37) in accordance with earlier findings [13–17]. In comparison, Andersen et al. [13] found a stronger association (r = - 0.49) than was observed in the present study, while others have found weaker associations (r = - 0.31 to—0.09) [15, 17]. Aadland and colleagues [14] recently showed that CRF measured by the Andersen test is a more accurate marker of cardiometabolic health compared to directly measured VO_2peak and time to exhaustion (TTE), determined from a graded treadmill protocol in Norwegian 10-year-old children. The standardized regression coefficient between the Andersen test and clustered cardiometabolic risk in the present study was lower than found by Aadland et al. [14]; r = - 0.45. Still, the Andersen test in the present study performed slightly better than both VO_2peak and TTE presented by Aadland et al. [14] as a marker of cardiometabolic health. Cardiorespiratory fitness is not regarded as one of the traditional cardiometabolic risk components and has been proclaimed as an overlooked and underutilized risk factor for cardiometabolic diseases along with PA [56, 57]. The undisputable positive association of CRF with cardiometabolic health, however, strongly implicates its importance and argues for the inclusion of CRF in clustered cardiometabolic risk scores.

The main strength of the present study was the use of international reference values to standardize the cardiometabolic risk factors. This approach makes it possible to directly compare otherwise population specific clustered risk scores to the reference material of international cardiometabolic risk values. More specifically, if other studies adapt the same standardization strategy as the present study, they could compare single and clustered risk scores both to the international reference values and the present study population. Thus, the strength of using the reference values will increase with its usage in different studies and populations, and will make it possible to look at secular trends in the future. Further, the relatively large population sample is a strength of the present study. However, the homogeneity within the group (i.e. rural children from one Norwegian county, primarily Caucasian and in a limited age-range), limits generalization of the results. The use of the Andersen aerobic fitness test to estimate VO_2peak could be a limitation of our findings, since the Andersen test is an indirect measure of CRF. However, the test has shown both validity and reliability in the target age-group [24, 61]. As discussed earlier, the Andersen test also performed better as a marker of cardiometabolic health than both a direct VO_2peak test and TTE [14]. Furthermore, this test is more feasible in large population studies than direct measurement of VO_2peak. The Andersen test is a suitable aerobic fitness test in children because the intermittent running reflects children’s natural running pattern and because it does not stigmatize children with a low CRF level. Dietary status was not registered in the ASK study and poses a limitation to the present study, since nutrition is a contributing factor to cardiometabolic risk [62].

Conclusions

This study is the first to standardize cardiometabolic risk factor levels in children according to international reference values. In comparison with international values, Norwegian children had significantly more favorable WC, DBP, glucose, HDL-C and CRF levels, but similar or less favorable levels of other cardiometabolic risk factors. The clustered cardiometabolic risk score (excluding CRF) was higher in the Norwegian children compared to the reference population. However, the Norwegian children`s CRF levels were more than 1 SD higher than the international mean. Adding CRF to the clustered cardiometabolic risk score lowered the score to below international values. CRF was associated with cardiometabolic risk, with low fit children scoring significantly higher on clustered cardiometabolic risk factors than children with higher CRF levels.

Supporting information

S1 Dataset. Supplementary data file including all material underlying the present study.

https://doi.org/10.1371/journal.pone.0220239.s001

(SAV)

Acknowledgments

The authors are thankful to the children and their families who participated in the ASK study, and also the teachers and principals at the 57 schools involved. We would like to acknowledge all test personnel, such as nurses, bioengineers, and students for their great effort during the period of data collection.

References

1. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362–74. pmid:15175438.
- View Article
- PubMed/NCBI
- Google Scholar
2. Magnussen CG, Smith KJ, Juonala M. When to prevent cardiovascular disease? As early as possible: lessons from prospective cohorts beginning in childhood. Curr Opin Cardiol. 2013;28(5):561–8. Epub 2013/08/10. pmid:23928921.
- View Article
- PubMed/NCBI
- Google Scholar
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53. pmid:9686693.
- View Article
- PubMed/NCBI
- Google Scholar
4. Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62. pmid:16182882.
- View Article
- PubMed/NCBI
- Google Scholar
5. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C, American Heart A, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–8. pmid:14744958.
- View Article
- PubMed/NCBI
- Google Scholar
6. Titmuss AT, Srinivasan S. Metabolic syndrome in children and adolescents: Old concepts in a young population. J Paediatr Child Health. 2016;52(10):928–34. Epub 2016/06/15. pmid:27301065.
- View Article
- PubMed/NCBI
- Google Scholar
7. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003;157(8):821–7. pmid:12912790.
- View Article
- PubMed/NCBI
- Google Scholar
8. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents. Lancet. 2007;369(9579):2059–61. pmid:17586288.
- View Article
- PubMed/NCBI
- Google Scholar
9. Jolliffe CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J Am Coll Cardiol. 2007;49(8):891–8. pmid:17320748.
- View Article
- PubMed/NCBI
- Google Scholar
10. Stavnsbo M, Resaland GK, Anderssen SA, Steene-Johannessen J, Domazet SL, Skrede T, et al. Reference values for cardiometabolic risk scores in children and adolescents–suggesting a common standard. Atherosclerosis. 2018;278:299–306. pmid:30477756
- View Article
- PubMed/NCBI
- Google Scholar
11. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801. Epub 2002/03/15. pmid:11893790.
- View Article
- PubMed/NCBI
- Google Scholar
12. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women A Meta-analysis. Jama-J Am Med Assoc. 2009;301(19):2024–35. WOS:000266159600027. pmid:19454641
- View Article
- PubMed/NCBI
- Google Scholar
13. Andersen LB, Bugge A, Dencker M, Eiberg S, El-Naaman B. The association between physical activity, physical fitness and development of metabolic disorders. Int J Pediatr Obes. 2011;6 Suppl 1:29–34. pmid:21905813.
- View Article
- PubMed/NCBI
- Google Scholar
14. Aadland E, Kvalheim OM, Rajalahti T, Skrede T, Resaland GK. Aerobic fitness and metabolic health in children: A clinical validation of directly measured maximal oxygen consumption versus performance measures as markers of health. Prev Med Rep. 2017;7:74–6. Epub 2017/06/09. pmid:28593126; PubMed Central PMCID: PMC5458058.
- View Article
- PubMed/NCBI
- Google Scholar
15. Ekelund U, Anderssen SA, Froberg K, Sardinha LB, Andersen LB, Brage S, et al. Independent associations of physical activity and cardiorespiratory fitness with metabolic risk factors in children: the European youth heart study. Diabetologia. 2007;50(9):1832–40. pmid:17641870.
- View Article
- PubMed/NCBI
- Google Scholar
16. Resaland GK, Mamen A, Boreham C, Anderssen SA, Andersen LB. Cardiovascular risk factor clustering and its association with fitness in nine-year-old rural Norwegian children. Scand J Med Sci Sports. 2010;20(1):e112–20. pmid:19522748.
- View Article
- PubMed/NCBI
- Google Scholar
17. Bailey DP, Boddy LM, Savory LA, Denton SJ, Kerr CJ. Associations between cardiorespiratory fitness, physical activity and clustered cardiometabolic risk in children and adolescents: the HAPPY study. Eur J Pediatr. 2012;171(9):1317–23. pmid:22419363.
- View Article
- PubMed/NCBI
- Google Scholar
18. Resaland GK, Moe VF, Aadland E, Steene-Johannessen J, Glosvik O, Andersen JR, et al. Active Smarter Kids (ASK): Rationale and design of a cluster-randomized controlled trial investigating the effects of daily physical activity on children's academic performance and risk factors for non-communicable diseases. BMC Public Health. 2015;15:709. pmid:26215478; PubMed Central PMCID: PMC4517398.
- View Article
- PubMed/NCBI
- Google Scholar
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. pmid:3899825.
- View Article
- PubMed/NCBI
- Google Scholar
20. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit. 2001;6(2):107–10. pmid:11433132.
- View Article
- PubMed/NCBI
- Google Scholar
21. El Assaad MA, Topouchian JA, Darne BM, Asmar RG. Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit. 2002;7(4):237–41. pmid:12198340.
- View Article
- PubMed/NCBI
- Google Scholar
22. Carel JC, Leger J. Precocious puberty. New Engl J Med. 2008;358(22):2366–77. WOS:000256306700007.
- View Article
- Google Scholar
23. Andersen LB, Andersen TE, Andersen E, Anderssen SA. An intermittent running test to estimate maximal oxygen uptake: the Andersen test. J Sports Med Phys Fitness. 2008;48(4):434–7. Epub 2008/11/11. pmid:18997644.
- View Article
- PubMed/NCBI
- Google Scholar
24. Aadland E, Terum T, Mamen A, Andersen LB, Resaland GK. The Andersen aerobic fitness test: reliability and validity in 10-year-old children. Plos One. 2014;9(10):e110492. Epub 2014/10/21. pmid:25330388; PubMed Central PMCID: PMC4201545.
- View Article
- PubMed/NCBI
- Google Scholar
25. Aadland E, Andersen LB, Lerum O, Resaland GK. The Andersen aerobic fitness test: New peak oxygen consumption prediction equations in 10 and 16-year olds. Scand J Med Sci Sports. 2018;28(3):862–72. Epub 2017/09/25. pmid:28940675.
- View Article
- PubMed/NCBI
- Google Scholar
26. WMA. Ethical Principles for Medical Research Involving Human Subjects. World Medical Association General Assembly, Helsinki. 1964.
27. Andersen LB, Harro M, Sardinha LB, Froberg K, Ekelund U, Brage S, et al. Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study). Lancet. 2006;368(9532):299–304. pmid:16860699.
- View Article
- PubMed/NCBI
- Google Scholar
28. Andersen LB, Henckel P, Saltin B. Risk-Factors for Cardiovascular-Disease in 16-19-Year-Old Teenagers. Journal of Internal Medicine. 1989;225(3):157–63. WOS:A1989U409400003. pmid:2703797
- View Article
- PubMed/NCBI
- Google Scholar
29. Wynder EL, Williams CL, Laakso K, Levenstein M. Screening for risk factors for chronic disease in children from fifteen countries. Prev Med. 1981;10(2):121–32. Epub 1981/03/01. pmid:7220497.
- View Article
- PubMed/NCBI
- Google Scholar
30. Kollias A, Dafni M, Poulidakis E, Ntineri A, Stergiou GS. Out-of-office blood pressure and target organ damage in children and adolescents: a systematic review and meta-analysis. J Hypertens. 2014;32(12):2315–31; discussion 31. pmid:25304469.
- View Article
- PubMed/NCBI
- Google Scholar
31. Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117(25):3171–80. pmid:18559702; PubMed Central PMCID: PMC3568631.
- View Article
- PubMed/NCBI
- Google Scholar
32. Beevers G, Lip GY, O'Brien E. ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques. BMJ. 2001;322(7292):981–5. Epub 2001/04/20. pmid:11312235; PubMed Central PMCID: PMC1120141.
- View Article
- PubMed/NCBI
- Google Scholar
33. Mourad JJ. The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target. Vasc Health Risk Manag. 2008;4(6):1315–25. Epub 2008/01/01. pmid:19337545; PubMed Central PMCID: PMC2663439.
- View Article
- PubMed/NCBI
- Google Scholar
34. Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37–55. Epub 2016/11/20. pmid:27863813; PubMed Central PMCID: PMC5220163.
- View Article
- PubMed/NCBI
- Google Scholar
35. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117–24. Epub 1997/04/17. pmid:9099655.
- View Article
- PubMed/NCBI
- Google Scholar
36. Jones DW, Appel LJ, Sheps SG, Roccella EJ, Lenfant C. Measuring blood pressure accurately: new and persistent challenges. JAMA. 2003;289(8):1027–30. Epub 2003/02/25. pmid:12597757.
- View Article
- PubMed/NCBI
- Google Scholar
37. Duncombe SL, Voss C, Harris KC. Oscillometric and auscultatory blood pressure measurement methods in children: a systematic review and meta-analysis. J Hypertens. 2017;35(2):213–24. Epub 2016/11/22. pmid:27870656.
- View Article
- PubMed/NCBI
- Google Scholar
38. Tolonen H, Koponen P, Naska A, Mannisto S, Broda G, Palosaari T, et al. Challenges in standardization of blood pressure measurement at the population level. BMC Med Res Methodol. 2015;15:33. Epub 2015/04/17. pmid:25880766; PubMed Central PMCID: PMC4403933.
- View Article
- PubMed/NCBI
- Google Scholar
39. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr-Us. 2004;144(1):47–55. WOS:000188091100010. pmid:14722518
- View Article
- PubMed/NCBI
- Google Scholar
40. Andersen LB, Boreham CA, Young IS, Davey Smith G, Gallagher AM, Murray L, et al. Insulin sensitivity and clustering of coronary heart disease risk factors in young adults. The Northern Ireland Young Hearts Study. Prev Med. 2006;42(1):73–7. pmid:16330091.
- View Article
- PubMed/NCBI
- Google Scholar
41. Farsani SF, van der Aa MP, van der Vorst MMJ, Knibbe CAJ, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia. 2013;56(7):1471–88. WOS:000319881300004. pmid:23677041
- View Article
- PubMed/NCBI
- Google Scholar
42. Steene-Johannessen J, Kolle E, Anderssen SA, Andersen LB. Cardiovascular disease risk factors in a population-based sample of Norwegian children and adolescents. Scand J Clin Lab Invest. 2009;69(3):380–6. pmid:19153936.
- View Article
- PubMed/NCBI
- Google Scholar
43. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650–6. pmid:9614255.
- View Article
- PubMed/NCBI
- Google Scholar
44. Nicklas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med. 2002;23 Suppl 1:S39–43. pmid:12012261.
- View Article
- PubMed/NCBI
- Google Scholar
45. Bertrais S, Balkau B, Charles MA, Vol S, Calvet C, Tichet J, et al. Puberty-associated differences in total cholesterol and triglyceride levels according to sex in French children aged 10–13 years. Ann Epidemiol. 2000;10(5):316–23. Epub 2000/08/16. pmid:10942880.
- View Article
- PubMed/NCBI
- Google Scholar
46. Sorensen K, Mouritsen A, Aksglaede L, Hagen CP, Mogensen SS, Juul A. Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Horm Res Paediatr. 2012;77(3):137–45. Epub 2012/04/18. pmid:22508036.
- View Article
- PubMed/NCBI
- Google Scholar
47. Aksglaede L, Sorensen K, Petersen JH, Skakkebaek NE, Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics. 2009;123(5):e932–9. Epub 2009/05/01. pmid:19403485.
- View Article
- PubMed/NCBI
- Google Scholar
48. Assmann G, Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III8–14. Epub 2004/06/17. pmid:15198960.
- View Article
- PubMed/NCBI
- Google Scholar
49. Kwiterovich PO, Vining EPG, Pyzik P, Skolasky R, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. Jama-J Am Med Assoc. 2003;290(7):912–20. WOS:000184828800028. pmid:12928468
- View Article
- PubMed/NCBI
- Google Scholar
50. Dron JS, Hegele RA. Genetics of Triglycerides and the Risk of Atherosclerosis. Curr Atheroscler Rep. 2017;19(7):31. Epub 2017/05/24. pmid:28534127; PubMed Central PMCID: PMC5440481.
- View Article
- PubMed/NCBI
- Google Scholar
51. WHO. Adolescent obesity and related behaviours: trends and inequalities in the WHO European Region, 2002–2014. Observations from the Health Behaviour in School-aged Children (HBSC) WHO collaborative cross-national study. http://www.euro.who.int/__data/assets/pdf_file/0019/339211/WHO_ObesityReport_2017_v3.pdf: 2017.
52. Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of Obesity and Severe Obesity in US Children, 1999–2016. Pediatrics. 2018. Epub 2018/02/28. pmid:29483202.
- View Article
- PubMed/NCBI
- Google Scholar
53. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk—a review of the literature. Eur J Clin Nutr. 2010;64(1):16–22. Epub 2009/08/06. pmid:19654593.
- View Article
- PubMed/NCBI
- Google Scholar
54. Franks PW, Hanson RL, Knowler WC, Moffett C, Enos G, Infante AM, et al. Childhood predictors of young-onset type 2 diabetes. Diabetes. 2007;56(12):2964–72. Epub 2007/08/28. pmid:17720898.
- View Article
- PubMed/NCBI
- Google Scholar
55. Garnett SP, Baur LA, Srinivasan S, Lee JW, Cowell CT. Body mass index and waist circumference in midchildhood and adverse cardiovascular disease risk clustering in adolescence. American Journal of Clinical Nutrition. 2007;86(3):549–55. WOS:000249485300005. pmid:17823416
- View Article
- PubMed/NCBI
- Google Scholar
56. Ross R, Blair SN, Arena R, Church TS, Despres JP, Franklin BA, et al. Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association. Circulation. 2016;134(24):e653–e99. Epub 2016/11/25. pmid:27881567.
- View Article
- PubMed/NCBI
- Google Scholar
57. Myers J, McAuley P, Lavie CJ, Despres JP, Arena R, Kokkinos P. Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. Prog Cardiovasc Dis. 2015;57(4):306–14. pmid:25269064.
- View Article
- PubMed/NCBI
- Google Scholar
58. Blair SN. Physical inactivity: the biggest public health problem of the 21st century. Br J Sports Med. 2009;43(1):1–2. pmid:19136507.
- View Article
- PubMed/NCBI
- Google Scholar
59. Resaland GK, Mamen A, Anderssen SA, Andersen LB. Cardiorespiratory fitness and body mass index values in 9-year-old rural Norwegian children. Acta Paediatr. 2009;98(4):687–92. pmid:19133872.
- View Article
- PubMed/NCBI
- Google Scholar
60. Cooper AR, Goodman A, Page AS, Sherar LB, Esliger DW, van Sluijs EMF, et al. Objectively measured physical activity and sedentary time in youth: the International children's accelerometry database (ICAD). Int J Behav Nutr Phy. 2015;12. ARTN 113 WOS:000361361500005. pmid:26377803
- View Article
- PubMed/NCBI
- Google Scholar
61. Aadland E, Andersen LB, Lerum O, Resaland GK. The Andersen aerobic fitness test: New peak oxygen consumption prediction equations in 10 and 16-year olds. Scand J Med Sci Sports. 2017. Epub 2017/09/25. pmid:28940675.
- View Article
- PubMed/NCBI
- Google Scholar
62. Funtikova AN, Navarro E, Bawaked RA, Fito M, Schroder H. Impact of diet on cardiometabolic health in children and adolescents. Nutr J. 2015;14:118. Epub 2015/11/18. PubMed Central PMCID: PMC4647337. pmid:26574072
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362–74. pmid:15175438.
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Magnussen CG, Smith KJ, Juonala M. When to prevent cardiovascular disease? As early as possible: lessons from prospective cohorts beginning in childhood. Curr Opin Cardiol. 2013;28(5):561–8. Epub 2013/08/10. pmid:23928921.
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53. pmid:9686693.
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62. pmid:16182882.
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C, American Heart A, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–8. pmid:14744958.
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Titmuss AT, Srinivasan S. Metabolic syndrome in children and adolescents: Old concepts in a young population. J Paediatr Child Health. 2016;52(10):928–34. Epub 2016/06/15. pmid:27301065.
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003;157(8):821–7. pmid:12912790.
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents. Lancet. 2007;369(9579):2059–61. pmid:17586288.
View Article
PubMed/NCBI
Google Scholar

[30] View Article

[31] PubMed/NCBI

[32] Google Scholar

[ref9] 9. Jolliffe CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J Am Coll Cardiol. 2007;49(8):891–8. pmid:17320748.
View Article
PubMed/NCBI
Google Scholar

[34] View Article

[35] PubMed/NCBI

[36] Google Scholar

[ref10] 10. Stavnsbo M, Resaland GK, Anderssen SA, Steene-Johannessen J, Domazet SL, Skrede T, et al. Reference values for cardiometabolic risk scores in children and adolescents–suggesting a common standard. Atherosclerosis. 2018;278:299–306. pmid:30477756
View Article
PubMed/NCBI
Google Scholar

[38] View Article

[39] PubMed/NCBI

[40] Google Scholar

[ref11] 11. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801. Epub 2002/03/15. pmid:11893790.
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref12] 12. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women A Meta-analysis. Jama-J Am Med Assoc. 2009;301(19):2024–35. WOS:000266159600027. pmid:19454641
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref13] 13. Andersen LB, Bugge A, Dencker M, Eiberg S, El-Naaman B. The association between physical activity, physical fitness and development of metabolic disorders. Int J Pediatr Obes. 2011;6 Suppl 1:29–34. pmid:21905813.
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref14] 14. Aadland E, Kvalheim OM, Rajalahti T, Skrede T, Resaland GK. Aerobic fitness and metabolic health in children: A clinical validation of directly measured maximal oxygen consumption versus performance measures as markers of health. Prev Med Rep. 2017;7:74–6. Epub 2017/06/09. pmid:28593126; PubMed Central PMCID: PMC5458058.
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref15] 15. Ekelund U, Anderssen SA, Froberg K, Sardinha LB, Andersen LB, Brage S, et al. Independent associations of physical activity and cardiorespiratory fitness with metabolic risk factors in children: the European youth heart study. Diabetologia. 2007;50(9):1832–40. pmid:17641870.
View Article
PubMed/NCBI
Google Scholar

[58] View Article

[59] PubMed/NCBI

[60] Google Scholar

[ref16] 16. Resaland GK, Mamen A, Boreham C, Anderssen SA, Andersen LB. Cardiovascular risk factor clustering and its association with fitness in nine-year-old rural Norwegian children. Scand J Med Sci Sports. 2010;20(1):e112–20. pmid:19522748.
View Article
PubMed/NCBI
Google Scholar

[62] View Article

[63] PubMed/NCBI

[64] Google Scholar

[ref17] 17. Bailey DP, Boddy LM, Savory LA, Denton SJ, Kerr CJ. Associations between cardiorespiratory fitness, physical activity and clustered cardiometabolic risk in children and adolescents: the HAPPY study. Eur J Pediatr. 2012;171(9):1317–23. pmid:22419363.
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref18] 18. Resaland GK, Moe VF, Aadland E, Steene-Johannessen J, Glosvik O, Andersen JR, et al. Active Smarter Kids (ASK): Rationale and design of a cluster-randomized controlled trial investigating the effects of daily physical activity on children's academic performance and risk factors for non-communicable diseases. BMC Public Health. 2015;15:709. pmid:26215478; PubMed Central PMCID: PMC4517398.
View Article
PubMed/NCBI
Google Scholar

[70] View Article

[71] PubMed/NCBI

[72] Google Scholar

[ref19] 19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. pmid:3899825.
View Article
PubMed/NCBI
Google Scholar

[74] View Article

[75] PubMed/NCBI

[76] Google Scholar

[ref20] 20. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit. 2001;6(2):107–10. pmid:11433132.
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref21] 21. El Assaad MA, Topouchian JA, Darne BM, Asmar RG. Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit. 2002;7(4):237–41. pmid:12198340.
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref22] 22. Carel JC, Leger J. Precocious puberty. New Engl J Med. 2008;358(22):2366–77. WOS:000256306700007.
View Article
Google Scholar

[86] View Article

[87] Google Scholar

[ref23] 23. Andersen LB, Andersen TE, Andersen E, Anderssen SA. An intermittent running test to estimate maximal oxygen uptake: the Andersen test. J Sports Med Phys Fitness. 2008;48(4):434–7. Epub 2008/11/11. pmid:18997644.
View Article
PubMed/NCBI
Google Scholar

[89] View Article

[90] PubMed/NCBI

[91] Google Scholar

[ref24] 24. Aadland E, Terum T, Mamen A, Andersen LB, Resaland GK. The Andersen aerobic fitness test: reliability and validity in 10-year-old children. Plos One. 2014;9(10):e110492. Epub 2014/10/21. pmid:25330388; PubMed Central PMCID: PMC4201545.
View Article
PubMed/NCBI
Google Scholar

[93] View Article

[94] PubMed/NCBI

[95] Google Scholar

[ref25] 25. Aadland E, Andersen LB, Lerum O, Resaland GK. The Andersen aerobic fitness test: New peak oxygen consumption prediction equations in 10 and 16-year olds. Scand J Med Sci Sports. 2018;28(3):862–72. Epub 2017/09/25. pmid:28940675.
View Article
PubMed/NCBI
Google Scholar

[97] View Article

[98] PubMed/NCBI

[99] Google Scholar

[ref26] 26. WMA. Ethical Principles for Medical Research Involving Human Subjects. World Medical Association General Assembly, Helsinki. 1964.

[ref27] 27. Andersen LB, Harro M, Sardinha LB, Froberg K, Ekelund U, Brage S, et al. Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study). Lancet. 2006;368(9532):299–304. pmid:16860699.
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref28] 28. Andersen LB, Henckel P, Saltin B. Risk-Factors for Cardiovascular-Disease in 16-19-Year-Old Teenagers. Journal of Internal Medicine. 1989;225(3):157–63. WOS:A1989U409400003. pmid:2703797
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref29] 29. Wynder EL, Williams CL, Laakso K, Levenstein M. Screening for risk factors for chronic disease in children from fifteen countries. Prev Med. 1981;10(2):121–32. Epub 1981/03/01. pmid:7220497.
View Article
PubMed/NCBI
Google Scholar

[110] View Article

[111] PubMed/NCBI

[112] Google Scholar

[ref30] 30. Kollias A, Dafni M, Poulidakis E, Ntineri A, Stergiou GS. Out-of-office blood pressure and target organ damage in children and adolescents: a systematic review and meta-analysis. J Hypertens. 2014;32(12):2315–31; discussion 31. pmid:25304469.
View Article
PubMed/NCBI
Google Scholar

[114] View Article

[115] PubMed/NCBI

[116] Google Scholar

[ref31] 31. Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117(25):3171–80. pmid:18559702; PubMed Central PMCID: PMC3568631.
View Article
PubMed/NCBI
Google Scholar

[118] View Article

[119] PubMed/NCBI

[120] Google Scholar

[ref32] 32. Beevers G, Lip GY, O'Brien E. ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques. BMJ. 2001;322(7292):981–5. Epub 2001/04/20. pmid:11312235; PubMed Central PMCID: PMC1120141.
View Article
PubMed/NCBI
Google Scholar

[122] View Article

[123] PubMed/NCBI

[124] Google Scholar

[ref33] 33. Mourad JJ. The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target. Vasc Health Risk Manag. 2008;4(6):1315–25. Epub 2008/01/01. pmid:19337545; PubMed Central PMCID: PMC2663439.
View Article
PubMed/NCBI
Google Scholar

[126] View Article

[127] PubMed/NCBI

[128] Google Scholar

[ref34] 34. Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37–55. Epub 2016/11/20. pmid:27863813; PubMed Central PMCID: PMC5220163.
View Article
PubMed/NCBI
Google Scholar

[130] View Article

[131] PubMed/NCBI

[132] Google Scholar

[ref35] 35. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117–24. Epub 1997/04/17. pmid:9099655.
View Article
PubMed/NCBI
Google Scholar

[134] View Article

[135] PubMed/NCBI

[136] Google Scholar

[ref36] 36. Jones DW, Appel LJ, Sheps SG, Roccella EJ, Lenfant C. Measuring blood pressure accurately: new and persistent challenges. JAMA. 2003;289(8):1027–30. Epub 2003/02/25. pmid:12597757.
View Article
PubMed/NCBI
Google Scholar

[138] View Article

[139] PubMed/NCBI

[140] Google Scholar

[ref37] 37. Duncombe SL, Voss C, Harris KC. Oscillometric and auscultatory blood pressure measurement methods in children: a systematic review and meta-analysis. J Hypertens. 2017;35(2):213–24. Epub 2016/11/22. pmid:27870656.
View Article
PubMed/NCBI
Google Scholar

[142] View Article

[143] PubMed/NCBI

[144] Google Scholar

[ref38] 38. Tolonen H, Koponen P, Naska A, Mannisto S, Broda G, Palosaari T, et al. Challenges in standardization of blood pressure measurement at the population level. BMC Med Res Methodol. 2015;15:33. Epub 2015/04/17. pmid:25880766; PubMed Central PMCID: PMC4403933.
View Article
PubMed/NCBI
Google Scholar

[146] View Article

[147] PubMed/NCBI

[148] Google Scholar

[ref39] 39. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr-Us. 2004;144(1):47–55. WOS:000188091100010. pmid:14722518
View Article
PubMed/NCBI
Google Scholar

[150] View Article

[151] PubMed/NCBI

[152] Google Scholar

[ref40] 40. Andersen LB, Boreham CA, Young IS, Davey Smith G, Gallagher AM, Murray L, et al. Insulin sensitivity and clustering of coronary heart disease risk factors in young adults. The Northern Ireland Young Hearts Study. Prev Med. 2006;42(1):73–7. pmid:16330091.
View Article
PubMed/NCBI
Google Scholar

[154] View Article

[155] PubMed/NCBI

[156] Google Scholar

[ref41] 41. Farsani SF, van der Aa MP, van der Vorst MMJ, Knibbe CAJ, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia. 2013;56(7):1471–88. WOS:000319881300004. pmid:23677041
View Article
PubMed/NCBI
Google Scholar

[158] View Article

[159] PubMed/NCBI

[160] Google Scholar

[ref42] 42. Steene-Johannessen J, Kolle E, Anderssen SA, Andersen LB. Cardiovascular disease risk factors in a population-based sample of Norwegian children and adolescents. Scand J Clin Lab Invest. 2009;69(3):380–6. pmid:19153936.
View Article
PubMed/NCBI
Google Scholar

[162] View Article

[163] PubMed/NCBI

[164] Google Scholar

[ref43] 43. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650–6. pmid:9614255.
View Article
PubMed/NCBI
Google Scholar

[166] View Article

[167] PubMed/NCBI

[168] Google Scholar

[ref44] 44. Nicklas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med. 2002;23 Suppl 1:S39–43. pmid:12012261.
View Article
PubMed/NCBI
Google Scholar

[170] View Article

[171] PubMed/NCBI

[172] Google Scholar

[ref45] 45. Bertrais S, Balkau B, Charles MA, Vol S, Calvet C, Tichet J, et al. Puberty-associated differences in total cholesterol and triglyceride levels according to sex in French children aged 10–13 years. Ann Epidemiol. 2000;10(5):316–23. Epub 2000/08/16. pmid:10942880.
View Article
PubMed/NCBI
Google Scholar

[174] View Article

[175] PubMed/NCBI

[176] Google Scholar

[ref46] 46. Sorensen K, Mouritsen A, Aksglaede L, Hagen CP, Mogensen SS, Juul A. Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Horm Res Paediatr. 2012;77(3):137–45. Epub 2012/04/18. pmid:22508036.
View Article
PubMed/NCBI
Google Scholar

[178] View Article

[179] PubMed/NCBI

[180] Google Scholar

[ref47] 47. Aksglaede L, Sorensen K, Petersen JH, Skakkebaek NE, Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics. 2009;123(5):e932–9. Epub 2009/05/01. pmid:19403485.
View Article
PubMed/NCBI
Google Scholar

[182] View Article

[183] PubMed/NCBI

[184] Google Scholar

[ref48] 48. Assmann G, Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III8–14. Epub 2004/06/17. pmid:15198960.
View Article
PubMed/NCBI
Google Scholar

[186] View Article

[187] PubMed/NCBI

[188] Google Scholar

[ref49] 49. Kwiterovich PO, Vining EPG, Pyzik P, Skolasky R, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. Jama-J Am Med Assoc. 2003;290(7):912–20. WOS:000184828800028. pmid:12928468
View Article
PubMed/NCBI
Google Scholar

[190] View Article

[191] PubMed/NCBI

[192] Google Scholar

[ref50] 50. Dron JS, Hegele RA. Genetics of Triglycerides and the Risk of Atherosclerosis. Curr Atheroscler Rep. 2017;19(7):31. Epub 2017/05/24. pmid:28534127; PubMed Central PMCID: PMC5440481.
View Article
PubMed/NCBI
Google Scholar

[194] View Article

[195] PubMed/NCBI

[196] Google Scholar

[ref51] 51. WHO. Adolescent obesity and related behaviours: trends and inequalities in the WHO European Region, 2002–2014. Observations from the Health Behaviour in School-aged Children (HBSC) WHO collaborative cross-national study. http://www.euro.who.int/__data/assets/pdf_file/0019/339211/WHO_ObesityReport_2017_v3.pdf: 2017.

[ref52] 52. Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of Obesity and Severe Obesity in US Children, 1999–2016. Pediatrics. 2018. Epub 2018/02/28. pmid:29483202.
View Article
PubMed/NCBI
Google Scholar

[199] View Article

[200] PubMed/NCBI

[201] Google Scholar

[ref53] 53. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk—a review of the literature. Eur J Clin Nutr. 2010;64(1):16–22. Epub 2009/08/06. pmid:19654593.
View Article
PubMed/NCBI
Google Scholar

[203] View Article

[204] PubMed/NCBI

[205] Google Scholar

[ref54] 54. Franks PW, Hanson RL, Knowler WC, Moffett C, Enos G, Infante AM, et al. Childhood predictors of young-onset type 2 diabetes. Diabetes. 2007;56(12):2964–72. Epub 2007/08/28. pmid:17720898.
View Article
PubMed/NCBI
Google Scholar

[207] View Article

[208] PubMed/NCBI

[209] Google Scholar

[ref55] 55. Garnett SP, Baur LA, Srinivasan S, Lee JW, Cowell CT. Body mass index and waist circumference in midchildhood and adverse cardiovascular disease risk clustering in adolescence. American Journal of Clinical Nutrition. 2007;86(3):549–55. WOS:000249485300005. pmid:17823416
View Article
PubMed/NCBI
Google Scholar

[211] View Article

[212] PubMed/NCBI

[213] Google Scholar

[ref56] 56. Ross R, Blair SN, Arena R, Church TS, Despres JP, Franklin BA, et al. Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association. Circulation. 2016;134(24):e653–e99. Epub 2016/11/25. pmid:27881567.
View Article
PubMed/NCBI
Google Scholar

[215] View Article

[216] PubMed/NCBI

[217] Google Scholar

[ref57] 57. Myers J, McAuley P, Lavie CJ, Despres JP, Arena R, Kokkinos P. Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. Prog Cardiovasc Dis. 2015;57(4):306–14. pmid:25269064.
View Article
PubMed/NCBI
Google Scholar

[219] View Article

[220] PubMed/NCBI

[221] Google Scholar

[ref58] 58. Blair SN. Physical inactivity: the biggest public health problem of the 21st century. Br J Sports Med. 2009;43(1):1–2. pmid:19136507.
View Article
PubMed/NCBI
Google Scholar

[223] View Article

[224] PubMed/NCBI

[225] Google Scholar

[ref59] 59. Resaland GK, Mamen A, Anderssen SA, Andersen LB. Cardiorespiratory fitness and body mass index values in 9-year-old rural Norwegian children. Acta Paediatr. 2009;98(4):687–92. pmid:19133872.
View Article
PubMed/NCBI
Google Scholar

[227] View Article

[228] PubMed/NCBI

[229] Google Scholar

[ref60] 60. Cooper AR, Goodman A, Page AS, Sherar LB, Esliger DW, van Sluijs EMF, et al. Objectively measured physical activity and sedentary time in youth: the International children's accelerometry database (ICAD). Int J Behav Nutr Phy. 2015;12. ARTN 113 WOS:000361361500005. pmid:26377803
View Article
PubMed/NCBI
Google Scholar

[231] View Article

[232] PubMed/NCBI

[233] Google Scholar

[ref61] 61. Aadland E, Andersen LB, Lerum O, Resaland GK. The Andersen aerobic fitness test: New peak oxygen consumption prediction equations in 10 and 16-year olds. Scand J Med Sci Sports. 2017. Epub 2017/09/25. pmid:28940675.
View Article
PubMed/NCBI
Google Scholar

[235] View Article

[236] PubMed/NCBI

[237] Google Scholar

[ref62] 62. Funtikova AN, Navarro E, Bawaked RA, Fito M, Schroder H. Impact of diet on cardiometabolic health in children and adolescents. Nutr J. 2015;14:118. Epub 2015/11/18. PubMed Central PMCID: PMC4647337. pmid:26574072
View Article
PubMed/NCBI
Google Scholar

[239] View Article

[240] PubMed/NCBI

[241] Google Scholar

Figures

Abstract

Objective

Methods

Results

Conclusions

Introduction

Materials and methods

Design and population

Blood sampling

Resting blood pressure

Anthropometry and sexual maturity

BMI.

Waist circumference.

Maturity.

Demographic characteristics

Cardiorespiratory fitness

Ethics

Statistics

Results

Discussion

Conclusions

Supporting information

S1 Dataset. Supplementary data file including all material underlying the present study.

Acknowledgments

References